SPINEGUARD overview

Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) sensing technology to secure and streamline the insertion of bone implants, and XinRong Medical Group, a China leader in medical technology, announced today the placement of a large purchase order of PediGuard devices and the completion of a capital increase primarily intended to fund the registration of the whole SpineGuard product portfolio by the Chinese NMPA (National...

Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announced today its first half 2023 revenue. Pierre Jérôme, Co-founder, Chairman and CEO of SpineGuard, said : “Our product sales in Q2 are extremely contrasted between the United States and the rest of the world. The temporary setback in the US translates the low level of orders from our...

Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, reports on its Annual Shareholders’ Meeting held on June 29, 2023 at 10:00am, on its second call at the offices of the law firm Ashurst Paris, located at 18 square Edouard VII, 75009 Paris. The shareholders present or represented were holding 8,922,729 shares representing a quorum of 22.85%. All...

Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announces that, due to lack of quorum, its Annual Shareholders’ meeting convened on June 8, 2023, could not be held. Shareholders are hereby notified that the Annual Shareholders’ Meeting will be held on second call on Thursday, June 29, 2023, at 10:00 am at the offices of the law firm Ashurst...

Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants announced today that they implemented an innovative equity line financing of a maximum of €7.5M with Nice & Green, an investment firm partnering with the Company since 2017. In a volatile macroeconomic context, this innovative financing (the "Horizon Program") aims at securing the Company's...